Clinical Site 165 — Raleigh, North Carolina

Clinical Site 165 is a clinical research site located in Raleigh, North Carolina, United States 27587.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Clinical Site 165 has participated in 1 clinical trials.

Therapeutic areas: Diabetic Retinopathy.

Sponsors: OcuTerra Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Site 165?

Clinical Site 165 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Site 165 conducted?

Clinical Site 165 has 1 clinical trials on record. Their work covers Diabetic Retinopathy.

Is Clinical Site 165 accredited by Crixeo Health?

Clinical Site 165 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Site 165?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.